400 related articles for article (PubMed ID: 33579377)
1. MiRNA-mediated EMT and CSCs in cancer chemoresistance.
Dong B; Li S; Zhu S; Yi M; Luo S; Wu K
Exp Hematol Oncol; 2021 Feb; 10(1):12. PubMed ID: 33579377
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer.
Yuan W; Ji J; Shu Y; Chen J; Liu S; Wu L; Zhou Z; Liu Z; Tang Q; Zhang X; Shu X
J Mol Med (Berl); 2019 Jan; 97(1):89-102. PubMed ID: 30460377
[TBL] [Abstract][Full Text] [Related]
3. The MyoD family inhibitor domain-containing protein enhances the chemoresistance of cancer stem cells in the epithelial state by increasing β-catenin activity.
Chen CJ; Yang CJ; Yang SF; Huang MS; Liu YP
Oncogene; 2020 Mar; 39(11):2377-2390. PubMed ID: 31911618
[TBL] [Abstract][Full Text] [Related]
4. Communication Between Epithelial-Mesenchymal Plasticity and Cancer Stem Cells: New Insights Into Cancer Progression.
Zheng X; Dai F; Feng L; Zou H; Feng L; Xu M
Front Oncol; 2021; 11():617597. PubMed ID: 33968721
[TBL] [Abstract][Full Text] [Related]
5. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
Garg M
Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
[TBL] [Abstract][Full Text] [Related]
6. Identification and Clinical Significance of Pancreatic Cancer Stem Cells and Their Chemotherapeutic Drug Resistance.
Kuo YC; Kou HW; Hsu CP; Lo CH; Hwang TL
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108495
[TBL] [Abstract][Full Text] [Related]
7. Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition.
Jin W
Cells; 2020 Jan; 9(1):. PubMed ID: 31952344
[TBL] [Abstract][Full Text] [Related]
8. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
9. The evolving concept of cancer stem-like cells in thyroid cancer and other solid tumors.
Hardin H; Zhang R; Helein H; Buehler D; Guo Z; Lloyd RV
Lab Invest; 2017 Oct; 97(10):1142-1151. PubMed ID: 28394318
[TBL] [Abstract][Full Text] [Related]
10. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
11. Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies.
Tanabe S; Quader S; Cabral H; Ono R
Front Pharmacol; 2020; 11():904. PubMed ID: 32625096
[TBL] [Abstract][Full Text] [Related]
12. Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance.
Palamaris K; Felekouras E; Sakellariou S
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771695
[TBL] [Abstract][Full Text] [Related]
13. Low Expression of miR-466f-3p Sustains Epithelial to Mesenchymal Transition in Sonic Hedgehog Medulloblastoma Stem Cells Through Vegfa-Nrp2 Signaling Pathway.
Besharat ZM; Sabato C; Po A; Gianno F; Abballe L; Napolitano M; Miele E; Giangaspero F; Vacca A; Catanzaro G; Ferretti E
Front Pharmacol; 2018; 9():1281. PubMed ID: 30483126
[TBL] [Abstract][Full Text] [Related]
14. Signalling mechanism(s) of epithelial-mesenchymal transition and cancer stem cells in tumour therapeutic resistance.
Cai Z; Cao Y; Luo Y; Hu H; Ling H
Clin Chim Acta; 2018 Aug; 483():156-163. PubMed ID: 29709449
[TBL] [Abstract][Full Text] [Related]
15. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
Du B; Shim JS
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
17. microRNA regulation of human pancreatic cancer stem cells.
Xu YF; Hannafon BN; Ding WQ
Stem Cell Investig; 2017; 4():5. PubMed ID: 28217707
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
19. A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling.
Bocci F; Jolly MK; George JT; Levine H; Onuchic JN
Oncotarget; 2018 Jul; 9(52):29906-29920. PubMed ID: 30042822
[TBL] [Abstract][Full Text] [Related]
20. Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma.
Chiou GY; Cherng JY; Hsu HS; Wang ML; Tsai CM; Lu KH; Chien Y; Hung SC; Chen YW; Wong CI; Tseng LM; Huang PI; Yu CC; Hsu WH; Chiou SH
J Control Release; 2012 Apr; 159(2):240-50. PubMed ID: 22285547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
